论文信息 - P436 Efficacy and safety of intravenous ustekinumab re-induction therapy in Crohn’s disease patients with secondary loss of response to ustekinumab maintenance therapy: Week 16 results from the POWER trial - 字舞流文

P436 Efficacy and safety of intravenous ustekinumab re-induction therapy in Crohn’s disease patients with secondary loss of response to ustekinumab maintenance therapy: Week 16 results from the POWER trial

C. J. van der Woude | S. Schreiber | W. Langholff | B. Salzberg | C. Gasink | I. Marín-Jiménez | B. Feagan | E. Schnoy | M. Nazar | T. Baker | C. Busse | D. Wolf | S. Lee | S. Borghorst | B. Godwin